Position in RNA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$48,506
New position
Shares Held
3,628
first reported quarter
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in RNA
reported options exposure · as of Mar 31, 2026CallValue
$69,524
CallShares
5,200
PutValue
$288,792
PutShares
21,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Walleye Trading LLC holds $17,472,598 across 36 Biotechnology names. RNA ranks #28 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,390 | $8,027,729 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,756 | $1,904,487 | |
| 3 | INSM |
INSMED Inc
|
7,620 | $1,246,022 | |
| 4 | ABVX |
Abivax S.A.
|
9,769 | $1,087,778 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
15,086 | $717,641 | |
| 6 | BNTX |
BioNTech SE
|
6,431 | $571,587 | |
| 7 | FOLD |
AMICUS THERAPEUTICS, INC.
|
25,604 | $370,233 | |
| 8 | MRNA |
Moderna, Inc.
|
7,257 | $368,655 |
All Filings in RNA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $288,792 | 21,600 | Put | Sole | 2026-05-11 | |
| 2026-03-31 | $48,506 | 3,628 | Shares | Sole | 2026-05-11 | |
| 2026-03-31 | $69,524 | 5,200 | Call | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||